DASA inhibits the interaction between Src tyrosine kinase and hepatocyte growth factor receptor, enhancing the sensitivity of cancer cells to tumor necrosis factor-related apoptosis-inducing ligands [48,49,50]. This evidence concerns the gene MET and cancer.